Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Adv Carbohydr Chem Biochem ; 80: 121-164, 2021.
Article in English | MEDLINE | ID: mdl-34872655

ABSTRACT

Heparin and heparan sulfate are members of the glycosaminoglycan family that are involved in a multitude of biological processes. The great interests in the anticoagulant properties of heparin have stimulated major advances in synthetic strategies toward clinically effective analogues, as demonstrated importantly by the approval of the fully synthetic pentasaccharide fragment, termed fondaparinux (Arixtra®), of the heparin macromolecule for treatment of deep-vein thrombosis. Given the highly complex nature of heparin and heparan sulfate, the chemical synthesis of their components is a challenging endeavor. In the past decade, multiple approaches have been developed to improve the overall synthetic efficiency. New strategies have emerged that can generate libraries of oligosaccharide components of heparin and heparan sulfate. This article discusses recent developments in the assembly of heparin and heparan sulfate oligosaccharides and the associated challenges in their synthesis.


Subject(s)
Heparin , Heparitin Sulfate , Anticoagulants , Glycosaminoglycans , Oligosaccharides
2.
Chembiochem ; 17(2): 174-80, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26538065

ABSTRACT

The development of carbohydrate-based antitumor vaccines is an attractive approach towards tumor prevention and treatment. Herein, we focused on the ganglioside GM2 tumor-associated carbohydrate antigen (TACA), which is overexpressed in a wide range of tumor cells. GM2 was synthesized chemically and conjugated with a virus-like particle derived from bacteriophage Qß. Although the copper-catalyzed azide-alkyne cycloaddition reaction efficiently introduced 237 copies of GM2 per Qß, this construct failed to induce significant amounts of anti-GM2 antibodies compared to the Qß control. In contrast, GM2 immobilized on Qß through a thiourea linker elicited high titers of IgG antibodies that recognized GM2-positive tumor cells and effectively induced cell lysis through complement-mediated cytotoxicity. Thus, bacteriophage Qß is a suitable platform to boost antibody responses towards GM2, a representative member of an important class of TACA: the ganglioside.


Subject(s)
Allolevivirus/chemistry , Antibodies, Monoclonal , G(M2) Ganglioside/chemistry , Animals , Antibodies, Monoclonal/chemistry , Antibodies, Monoclonal/therapeutic use , Cancer Vaccines/chemical synthesis , Cancer Vaccines/chemistry , Carbohydrate Sequence , Cell Line, Tumor , Enzyme-Linked Immunosorbent Assay , G(M2) Ganglioside/chemical synthesis , G(M2) Ganglioside/therapeutic use , Mice , Molecular Sequence Data , Neoplasms/drug therapy
3.
J Org Chem ; 80(24): 12265-79, 2015 Dec 18.
Article in English | MEDLINE | ID: mdl-26574650

ABSTRACT

Heparan sulfates are implicated in a wide range of biological processes. A major challenge in deciphering their structure and activity relationship is the synthetic difficulties to access diverse heparan sulfate oligosaccharides with well-defined sulfation patterns. In order to expedite the synthesis, a divergent synthetic strategy was developed. By integrating chemical synthesis and two types of O-sulfo transferases, seven different hexasaccharides were obtained from a single hexasaccharide precursor. This approach combined the flexibility of chemical synthesis with the selectivity of enzyme-catalyzed sulfations, thus simplifying the overall synthetic operations. In an attempt to establish structure activity relationships of heparan sulfate binding with its receptor, the synthesized oligosaccharides were incorporated onto a glycan microarray, and their bindings with a growth factor FGF-2 were examined. The unique combination of chemical and enzymatic approaches expanded the capability of oligosaccharide synthesis. In addition, the well-defined heparan sulfate structures helped shine light on the fine substrate specificities of biosynthetic enzymes and confirm the potential sequence of enzymatic reactions in biosynthesis.


Subject(s)
Heparitin Sulfate/chemical synthesis , Oligosaccharides/chemical synthesis , Transferases/chemistry , Biocatalysis , Carbohydrate Sequence , Heparitin Sulfate/chemistry , Oligosaccharides/chemistry , Structure-Activity Relationship , Substrate Specificity , Transferases/metabolism
6.
J Biol Chem ; 287(25): 20996-1002, 2012 Jun 15.
Article in English | MEDLINE | ID: mdl-22528493

ABSTRACT

Heparan sulfate (HS), a highly sulfated polysaccharide, is biosynthesized through a pathway involving several enzymes. C(5)-epimerase (C(5)-epi) is a key enzyme in this pathway. C(5)-epi is known for being a two-way catalytic enzyme, displaying a "reversible" catalytic mode by converting a glucuronic acid to an iduronic acid residue, and vice versa. Here, we discovered that C(5)-epi can also serve as a one-way catalyst to convert a glucuronic acid to an iduronic acid residue, displaying an "irreversible" catalytic mode. Our data indicated that the reversible or irreversible catalytic mode strictly depends on the saccharide substrate structures. The biphasic mode of C(5)-epi offers a novel mechanism to regulate the biosynthesis of HS with the desired biological functions.


Subject(s)
Carbohydrate Epimerases/chemistry , Glucuronic Acid/chemistry , Heparitin Sulfate/chemistry , Iduronic Acid/chemistry , Carbohydrate Epimerases/genetics , Carbohydrate Epimerases/metabolism , Catalysis , Glucuronic Acid/genetics , Glucuronic Acid/metabolism , Heparitin Sulfate/biosynthesis , Heparitin Sulfate/genetics , Humans , Iduronic Acid/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism
7.
Chemistry ; 16(28): 8365-75, 2010 Jul 26.
Article in English | MEDLINE | ID: mdl-20623566

ABSTRACT

Heparin (HP) and heparan sulfate (HS) play important roles in many biological events. Increasing evidence has shown that the biological functions of HP and HS can be critically dependent upon their precise structures, including the position of the iduronic acids and sulfation patterns. However, unraveling the HP code has been extremely challenging due to the enormous structural variations. To overcome this hurdle, we investigated the possibility of assembling a library of HP/HS oligosaccharides using a preactivation-based, one-pot glycosylation method. A major challenge in HP/HS oligosaccharide synthesis is stereoselectivity in the formation of the cis-1,4-linkages between glucosamine and the uronic acid. Through screening, suitable protective groups were identified on the matching glycosyl donor and acceptor, leading to stereospecific formation of both the cis-1,4- and trans-1,4-linkages present in HP. The protective group chemistry designed was also very flexible. From two advanced thioglycosyl disaccharide intermediates, all of the required disaccharide modules for library preparation could be generated in a divergent manner, which greatly simplified building-block preparation. Furthermore, the reactivity-independent nature of the preactivation-based, one-pot approach enabled us to mix the building blocks. This allowed rapid assembly of twelve HP/HS hexasaccharides with systematically varied and precisely controlled backbone structures in a combinatorial fashion. The speed and the high yields achieved in glycoassembly without the need to use a large excess of building blocks highlighted the advantages of our approach, which can be of general use to facilitate the study of HP/HS biology. As a proof of principle, this panel of hexasaccharides was used to probe the effect of backbone sequence on binding with the fibroblast growth factor-2 (FGF-2). A trisaccharide sequence of 2-O-sulfated iduronic acid flanked by N-sulfated glucosamines was identified to be the minimum binding motif and N-sulfation was found to be critical. This provides useful information for further development of more potent compounds towards FGF-2 binding, which can have potential applications in wound healing and anticancer therapy.


Subject(s)
Heparin/chemistry , Heparitin Sulfate/chemistry , Oligosaccharides/chemistry , Glycosylation , Heparin/metabolism , Heparitin Sulfate/metabolism , Kinetics , Molecular Sequence Data , Molecular Structure , Protein Binding , Stereoisomerism
SELECTION OF CITATIONS
SEARCH DETAIL
...